|
Pseudomonas aeruginosa
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and
Figures
Table 1: Minimum Inhibitory Concentrations of
P. aeruginosa for Selected Antibiotics
Table 2:
Drug of Choice [Total Daily Dose
(Dosing Interval in Hours)]
Table 3: Special Infections [Total Daily Dose
(Dosing Interval in Hours)]
Table 4: Doses of IV Aminoglycosides in Specific
Infections [Total Daily Dose (Dosing Interval in Hours)]
Table 5: Recommended Dosages of Antimicrobial
Agents Given by the Intraventricular Route
Vignettes
Review
Article: Golnaz J, Zuravleff J.
Retinitis and Endophthalmitis.
2007.
Review
Article:
Grandis JR, Branstetter BF, Yu VL. The changing face
of malignant (necrotising) external otitis: clinical, radiological, and
anatomic correlations. Lancet Infect Dis 2004;4:34-39.
Review Article: Hoiby N. P.
aeruginosa in Cystic Fibrosis Patients Resists Host Defenses, Antibiotics.
Microbe 2006;12:571-577.
Review Article: Javey G, Zuravleff
J. Keratitis. 2007.
Review Article: Leid, JG.
Bacterial Biofilms Resist Key Host Defenses.
Microbe/Volume 4, Number 2, 2009.
Review Article:
O'Toole GA. How Pseudomonas aeruginosa regulates
surface behaviors. Microbe 2008;3:65-71.
Review Article: Poole K. Bacterial Multidrug Efflux Pumps Serve
Other Functions. Microbe 2008;3:179-185.
Review Article:
Efflux Pumps as a Mechanism
of Antimicrobial Resistance. 2008
Review Article: Raad I, Hanna H, and
Maki D. Intravascular Catheter-related Infections: Advances in Diagnosis,
Prevention and Management. The LANCET Infectious Diseases
2007;7:645-657.
Review
Article: Safdar N,
Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality
in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis. 2004;4(8): 519-27.
Review Article:
Tabibian JH, et al. Uropathogens and Host
Characteristics. J Clin Microbiol 2008;46:3980-3986.
Martinez-Solano L et al.
Chronic Pseudomonas aeruginosa Infection in Chronic
Obstructive Pulmonary Disease.
Clin Infect Dis. 2008;47(12):1526-33.
Dohar, JE
et al.
Differences in Bacteriologic Treatment Failures in Acute
Otitis Externa Between Ciprofloxacin/Dexamethasone and Neomycin/Polymyxin
B/Hydrocortisone: Results of a Combined Analysis. Curr Med
Res Opin. 2009;25(2):287-91.
Goldstein EJ, Citron DM, et al.
Introduction of Ertapenem into a Hospital Formulary:
Effect on Antimicrobial Usage and Improved in vitro Susceptibility of
Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53:5122-6.
King P, Lomovskaya O, et al.
In vitro Pharmacodynamics of Levofloxacin and Other
Aerosolized Antibiotics Under Multiple Conditions Relevant to Chronic Pulmonary
Infection in Cystic Fibrosis. Antimicrob Agents Chemother. 2010;54:143-8.
Kusne S, Eibling DE, et al.
Gangrenous Cellulitis Associated with Gram-Negative
Bacilli in Pancytopenic Patients. Am J Med. 1988;85:490-4.
Schechner V,
et al.
Gram-negative Bacteremia upon Hospital Admission: When
Should Pseudomonas aeruginosa be Suspected? Clin Infect
Dis. 2009;48:580-6.
Tam VH et al.
Outcomes of Bacteremia due to Pseudomonas aeruginosa with
Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the
Appropriateness of the Resistance Breakpoint. Clin
Infect Dis. 2008;46:862-7.
Authors
Shigeki Fujitani,
M.D,
Kathryn S. Moffett,
M.D.,
David L. Paterson, M.D.
Second Edition:
Ashish Acharya, M.D., David L. Paterson, M.D.
First Edition (1998):
Victor L. Yu
and David L. Paterson
|
www.antimicrobe.org